Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 28 March 2007. doi:10.1136/ard.2006.064287
Annals of the Rheumatic Diseases 2007;66:1195-1201
Copyright © 2007 BMJ Publishing Group Ltd & European League Against Rheumatism

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ard.2006.064287v1
66/9/1195    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ødegård, S.
Right arrow Articles by Uhlig, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ødegård, S.
Right arrow Articles by Uhlig, T.

EXTENDED REPORT

Pain and psychological health status over a 10-year period in patients with recent onset rheumatoid arthritis

Sigrid Ødegård 1, Arnstein Finset 2, Petter Mowinckel 1, Tore K. Kvien 1, Till Uhlig 1

1 Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
2 Department of Behavioural Sciences in Medicine, University of Oslo, Norway

Correspondence to:
Correspondence to:
Sigrid Ødegård
MD, Department of Rheumatology, Diakonhjemmet Hospital, N-0319 Oslo, Norway; sigrid.odegard{at}diakonsyk.no

Objective: To examine rheumatoid arthritis (RA) with short disease duration over 10 years, and to identify factors that are associated with the course of pain, depression and anxiety.

Methods: A cohort of 238 patients with RA (age 20–70 years, mean disease duration 2.3 years, 68% rheumatoid factor positive) was followed with assessments at baseline and after 1, 2, 5 and 10 years. Self-reported health status was assessed by pain on a 100 mm visual analogue scale, the Arthritis Impact Measurement Scales (AIMS), the 28-item version of General Health Questionnaires, and the Health Assessment Questionnaire. We also examined the erythrocyte sedimentation ratio, grip strength (kg) and radiographic progression of the hands (van der Heijde modified Sharp score). Repeated measures analyses of variance were used to explore the effect of time on measures of outcome among completers, whereas repeated measures analyses using a mixed model were applied to identify factors that were longitudinally associated with pain, depression and anxiety.

Results: At the various assessment points 30% had a visual analogue scale pain score of >=40 mm, 5–13% had an AIMS depression score of >=4.0 and 20–30% had an AIMS anxiety score of >=4.0. The perceived level of pain was explained longitudinally by anxiety, disease activity, physical function and female gender, depression by high disease activity and anxiety, whereas anxiety was explained by low disease activity and depression.

Conclusion: More patients had increased levels of anxiety (20–30%) than increased levels of depression (5–13%). Several factors, including anxiety, but not depression, were associated with the course of pain.


Abbreviations: AIMS, Arthritis Impact Measurement Scales; DMARD, disease-modifying antirheumatic drugs; ESR, erythrocyte sedimentation rate; GHQ, General Health Questionnaire; HAQ, Health Assessment Questionnaire RA, rheumatoid arthritis; RF, rheumatoid factor; VAS, visual analogue scale







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 BMJ Publishing Group Ltd & European League Against Rheumatism